Legend Net Income

Stocks . USA . 
Stock . Legend BiotechCorp
LEGN Stock  USD 64.17  0.09  0.14%   
Legend BiotechCorp fundamentals help investors to digest information that contributes to Legend BiotechCorp's financial success or failures. It also enables traders to predict the movement of Legend Stock. The fundamental analysis module provides a way to measure Legend BiotechCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Legend BiotechCorp stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
As of 31st of May 2023, Net Income is likely to drop to about (458.1 M). In addition to that, Net Income Common Stock is likely to drop to about (458.1 M).

Legend Net Income Analysis

Legend BiotechCorp's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Legend BiotechCorp Net Income

(458.1 Million)

Net Income 
 = 
(Rev + Gain) 
-  
(Exp + Loss) 
More About Net Income | All Equity Analysis

Current Legend BiotechCorp Net Income

    
  (445.72 M)  
Most of Legend BiotechCorp's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend BiotechCorp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Legend Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Legend BiotechCorp is extremely important. It helps to project a fair market value of Legend Stock properly, considering its historical fundamentals such as Net Income. Since Legend BiotechCorp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Legend BiotechCorp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Legend BiotechCorp's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Legend Consolidated Income

Consolidated Income

(458.1 Million)

Legend BiotechCorp Consolidated Income is very stable at the moment as compared to the past year. Legend BiotechCorp reported last year Consolidated Income of (446.35 Million)
Based on the recorded statements, Legend BiotechCorp reported net income of (445.72 Million). This is 230.6% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 178.06% higher than that of the company.

Legend Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Legend BiotechCorp's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Legend BiotechCorp could also be used in its relative valuation, which is a method of valuing Legend BiotechCorp by comparing valuation metrics of similar companies.
Legend BiotechCorp is currently under evaluation in net income category among related companies.

Legend BiotechCorp Institutional Holders

Institutional Holdings refers to the ownership stake in Legend BiotechCorp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Legend BiotechCorp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Legend BiotechCorp's value.
Last TransactionTypeSharesValue
Fmr Llc2023-03-31Common Shares16.4 M790.6 M
Hhlr Advisors Ltd2023-03-31Common Shares5.1 M247.4 M
Blackrock Inc2023-03-31Common Shares4.1 M199 M
Ra Capital Management Lp2023-03-31Common Shares2.4 M117.5 M
Capital World Investors2023-03-31Common Shares2.4 M115.2 M
Federated Hermes Inc2023-03-31Common Shares2.3 M112.8 M
Polar Capital Holdings Plc2023-03-31Common Shares2 M95.3 M
Capital International Investors2023-03-31Common Shares2 M94.1 M
Janus Henderson Group Plc2023-03-31Common Shares1.9 M93.5 M
Wellington Management Group Llp2023-03-31Common Shares1.8 M84.7 M
Johnson Johnson2023-03-31Common Shares1.6 M78.6 M

Legend Fundamentals

Return On Equity(0.96) %
Return On Asset(0.29) %
Operating Margin(5.00) %
Current Valuation8.02 B
Shares Outstanding180.35 M
Shares Owned by Insiders1.42 %
Shares Owned by Institutions39.26 %
Number of Shares Shorted4.68 M
Price to Book19.80 X
Price to Sales73.18 X
Revenue117 M
Gross Profit(284.01 M)
EBITDA(437.44 M)
Net Income(445.72 M)
Cash and Equivalents791.26 M
Cash per Share5.11 X
Total Debt260.93 M
Debt to Equity0.29 %
Current Ratio3.83 X
Book Value Per Share3.95 X
Cash Flow from Operations(200.03 M)
Short Ratio3.70 X
Earnings Per Share(3.14) X
Target Price80.9
Number of Employees1.39 K
Beta-0.0584
Market Capitalization11.39 B
Total Asset1.33 B
Working Capital801.33 M
Z Score25.91
Net Asset1.33 B

About Legend BiotechCorp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Legend BiotechCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend BiotechCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend BiotechCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2023
Net Income-446.3 M-458.1 M
Net Income Common Stock-446.3 M-458.1 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Legend BiotechCorp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bond Directory Now

   

Bond Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Legend BiotechCorp Piotroski F Score and Legend BiotechCorp Altman Z Score analysis. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Check out Legend BiotechCorp Piotroski F Score and Legend BiotechCorp Altman Z Score analysis. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY